EGFR and glioblastoma: Danhier et al. used convention enhanced delivery (CED) (see section Viral-Based Delivery) to deliver EGFR- and galectin-targeted siRNAs as chitosan lipid nanocapsides to orthotopic (U-87 MG cells) GBM mouse models (114).